Select Medical (NYSE:SEM) Stock Rating Upgraded by StockNews.com

Select Medical (NYSE:SEM) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report released on Wednesday.

A number of other equities analysts also recently issued reports on the company. Benchmark reiterated a “buy” rating and set a $48.00 price target on shares of Select Medical in a research note on Friday, November 1st. Royal Bank of Canada boosted their target price on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Finally, Bank of America started coverage on Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $40.75.

Select Medical Price Performance

SEM stock opened at $37.24 on Wednesday. The company has a market capitalization of $4.82 billion, a P/E ratio of 17.41, a price-to-earnings-growth ratio of 2.04 and a beta of 1.42. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical has a 52-week low of $22.26 and a 52-week high of $40.98. The business has a 50-day simple moving average of $34.69 and a two-hundred day simple moving average of $34.64.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.46 EPS. Research analysts expect that Select Medical will post 2.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Select Medical

Hedge funds have recently modified their holdings of the stock. Tidal Investments LLC bought a new stake in shares of Select Medical in the 1st quarter worth approximately $467,000. UniSuper Management Pty Ltd bought a new stake in shares of Select Medical in the 1st quarter worth approximately $730,000. First Eagle Investment Management LLC raised its holdings in shares of Select Medical by 14.8% in the 1st quarter. First Eagle Investment Management LLC now owns 275,559 shares of the health services provider’s stock worth $8,308,000 after purchasing an additional 35,512 shares during the period. Hood River Capital Management LLC purchased a new stake in shares of Select Medical during the second quarter worth $14,819,000. Finally, Comerica Bank lifted its position in shares of Select Medical by 30.0% during the first quarter. Comerica Bank now owns 68,485 shares of the health services provider’s stock worth $2,065,000 after acquiring an additional 15,824 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.